Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Neurobiology of Disease|December 9, 2022
Long wavelength light reduces the negative consequences of dim light at nightHuei-Bin Wang, David Zhou, Shu Hon Christopher Luk, et al.The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammationRichard W Chapman, Michael Minnicozzi, Chander S Celly, et al.Nature Communications|October 10, 2023
Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in miceStacy K Thomas, Max M Wattenberg, Shaanti Choi-Bose, et al.Proceedings of the National Academy of Sciences of the United States of America|April 6, 2013
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnoverChuandong Geng, Bin He, Limei Xu, et al.Plos One|November 5, 2016
Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex FormationAnissa S H Chan, Adria Bykowski Jonas, Xiaohong Qiu, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2025
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapyAlison T Stopeck, Maysa Abu-Khalaf, Virginia Borges, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonistsYounong Yu, Michael P Dwyer, Jianping Chao, et al.Trials|October 24, 2023
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorderOrli S Schwartz, Paul Amminger, Bernard T Baune, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy VolunteersNandita Bose, Nadine R Ottoson, Xiaohong Qiu, et al.Journal of Medicinal Chemistry|December 22, 2006
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonistMichael P Dwyer, Younong Yu, Jianping Chao, et al.Pageof 5